The UAE has become the second country to approve once-daily, oral pill - Lipfendra - to treat adults with elevated low-density lipoprotein (LDL-C) cholesterol, a leading risk factor for cardiovascular disease.
Making the announcement, the Emirates Drug Establishment (EDE) explained that Lipfendra can also treat "certain inherited conditions" as long as it is cleared by a healthcare professional.
It is said to expand treatment options for adults and improve their quality of life.
Patients are advised to maintain a balanced diet and regular physical activity alongside the treatment.
The move is part of efforts by the UAE to authorise innovative medicines and expand treatment options for adults.
UAE Cabinet adopts AI Advisor System to support decision-making
UAE condemns hostile Iranian attack on Saudi tanker 'Sidr'
UAE expresses solidarity with Egypt, Jordan over victims of bus accident
Dubai steps up school safety with over 500 inspections
UAE scholarship programme helps 668 students pursue higher education
UAE strongly condemns Iranian attacks on neighbouring countries
UAE President invites Qatari Emir to attend UN Water Conference
Dubai Police honours Saudi national for saving man from drowning
